Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Anna-Maria Hoffmann-Vold, MD, PhD
Oslo University Hospital
Oslo, Norway
Disclosure(s): Bayer: Consultant (Terminated); Boehringer Ingelheime: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Jannsen: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medscape: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck Sharp & Dohme: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Roche: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Tatiana Sofía Rodríguez Reyna, MD, MSc
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Mexico City, Federal District, Mexico
Disclosure(s): Boehringer-Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Oral abstract session.
Presenting Author: Srijana Davuluri, MD, MBBS – Stanford School of Medicine
Presenting Author: Rachel Wallwork, MD – Johns Hopkins University
Presenting Author: Elana Bernstein, MD, MSc – Columbia University
Presenting Author: Julie Paik, MD, MHS – Johns Hopkins University
Presenting Author: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
Presenting Author: Noelle Kosarek, PhD – Dartmouth Geisel School of Medicine